Home      ||     Contact Us

#StayHome #StaySafe

BCG-Covid study on the elderly

ICMR- NIRT has initiated a multi-centric study to see if Bacille Calmette Guerin (BCG) vaccine can reduce the severity of COVID-19 disease among elderly individuals aged 60 years and above residing in hotspots for SARS-CoV2. This study will be carried out in 6 states of the country: Tamilnadu, Maharashtra, Gujarat, Madhya Pradesh, Rajasthan and Delhi in approximately 1000 healthy volunteers above 60-years of age. In Tamilnadu, this study will be done in close collaboration with the Greater Chennai Corporation and Department of Public Health of the State. The study will also document whether BCG vaccine can prevent the occurrence of the SARS-CoV-2 infection and its progression and death associated with COVID-19 among the elderly individuals.  The study uses the same BCG vaccine that is administered to newborn babies as a part of National Immunization programme for more than 50 years in this country. There are pre-set criteria in the study that will decide on eligibility of a volunteer to participate in this study. The study would enroll approximately 1000 participants and follow them closely  for a period of 6 months post vaccination.

Press News:
https://timesofindia.indiatimes.com/city/chennai/bcg-vaccine-to-be-given-to-tn-covid-19-patients-above-60-years/articleshow/76988675.cms
https://is.gd/Hq9UjW
https://www.thehindu.com/news/national/tamil-nadu/tamil-nadu-to-launch-trial-to-study-efficacy-of-bcg-vaccine-in-the-elderly/article32089636.ece


ICMR-NIRT lab team in action performing serology testing of the samples collected for
the National serology surveillance to monitor the trend of Sars-CoV-2 Infection transmission.

COVID-19 testing facility at NIRT

ICMR-NIRT was approved by the Indian Council of Medical Research as a COVID-19 testing laboratory on 21st April 2020. NIRT has a team of well-qualified staff and a fully-equipped laboratory for performing RT-PCR tests for detection of SARS-CoV-2. We are committed to doing everything in our capacity to help prevent the spread of COVID-19 and offer the best diagnostic services.

 

National COVID Sero-Surveillance

ICMR-NIRT has completed sample collection for National COVID Sero-survey, which determines if someone has been infected with Corona virus. A total of 24000 blood samples were collected across 60 districts all over India by the staff of National TB Prevalence Survey and the samples will be tested with the COVID-19 Kavach ELISA kits at ICMR-NIRT and ICMR-NIE laboratories.

Similarly, ICMR-NIRT has also collected 6500 blood samples across 13 hotspot cities all over India, for National COVID Sero-survey in Containment Zones, which determines if someone in the Containment Zone has been infected with Coronavirus.

 

ICMR-Covid-19 Portal

Tamil Nadu Updates

India Updates

Interviews on COVID-19 in DD Pothigai Channel given by:

Dr. G. Narendran, Scientist 'E'  (31/03/2020)

Dr. P K. Bhavani, Scientist 'D'  (01/04/2020)

Dr. S. Sriram, Scientist 'D'  (02/04/2020)

NUTRITION, LIFESTYLE & IMMUNITY - Dr. Hemalatha R Director, ICMR-NIN

ICMR-PRESS RELEASE : How India ramped up COVID-19 testing capacity

best free website hit counter  

About NIRTPublications | Achievements | Archives | Site Index | Disclaimer | Contact Us
© 2020 National Institute for Research in Tuberculosis. Designed and Maintained by R. Senthil Nathan, Library.